Navigo Proteins and Nostrum Biodiscovery join forces to develop Affilin ligand discovery using AI and molecular modelling
Navigo Proteins and Nostrum Biodiscovery have joined forces to co-develop a new cutting-edge pipeline of de novo designed ubiquitin-based Affilin ligands, expanding Navigo’s proprietary Affilin technology.